, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, 

® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by Coherus Biosciences, we had the pleasure of speaking with Ari Rosenberg, MD, who spoke about updates in nasopharyngeal carcinoma management. Dr Rosenberg is an assistant professor of medicine at the University of Chicago Medicine in Illinois. 

In our exclusive interview, Dr Rosenberg discussed current standard strategies for treating patients with nasopharyngeal cancer, the evolving role of toripalimab-tpzi (Loqtorzi) in this treatment paradigm, and how future advances in nasopharyngeal cancer management may impact the head and neck cancer treatment paradigm more broadly.

That’s all we have for today! Thank you for listening to this episode of 

, sponsored by Coherus Biosciences. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

 is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Podcasts

Dr Rosenberg discusses strategies for managing nasopharyngeal cancer and the role of toripalimab in this treatment paradigm.

Ari Rosenberg, MD

Articles

Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma